145 related articles for article (PubMed ID: 28158336)
1. Distinct Antidepressant-Like and Cognitive Effects of Antidepressants with Different Mechanisms of Action in Middle-Aged Female Mice.
Li Y; Sanchez C; Gulinello M
Int J Neuropsychopharmacol; 2017 Jun; 20(6):510-515. PubMed ID: 28158336
[TBL] [Abstract][Full Text] [Related]
2. Reversal of age-associated cognitive deficits is accompanied by increased plasticity-related gene expression after chronic antidepressant administration in middle-aged mice.
Li Y; Abdourahman A; Tamm JA; Pehrson AL; Sánchez C; Gulinello M
Pharmacol Biochem Behav; 2015 Aug; 135():70-82. PubMed ID: 26046533
[TBL] [Abstract][Full Text] [Related]
3. Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression.
du Jardin KG; Liebenberg N; Müller HK; Elfving B; Sanchez C; Wegener G
Psychopharmacology (Berl); 2016 Jul; 233(14):2813-25. PubMed ID: 27236785
[TBL] [Abstract][Full Text] [Related]
4. VORTIOXETINE - THE NEW ANTIDEPRESSANT AGENT WITH PROCOGNITIVE PROPERTIES.
Dziwota E; Olajossy M
Acta Pol Pharm; 2016 Nov; 73(6):1433-1437. PubMed ID: 29634095
[TBL] [Abstract][Full Text] [Related]
5. Vortioxetine promotes maturation of dendritic spines in vitro: A comparative study in hippocampal cultures.
Waller JA; Chen F; Sánchez C
Neuropharmacology; 2016 Apr; 103():143-54. PubMed ID: 26702943
[TBL] [Abstract][Full Text] [Related]
6. Effects of sertraline, duloxetine, vortioxetine, and idazoxan in the rat affective bias test.
Refsgaard LK; Haubro K; Pickering DS; Stuart SA; Robinson ES; Andreasen JT
Psychopharmacology (Berl); 2016 Oct; 233(21-22):3763-3770. PubMed ID: 27572627
[TBL] [Abstract][Full Text] [Related]
7. Serotonergic receptor mechanisms underlying antidepressant-like action in the progesterone withdrawal model of hormonally induced depression in rats.
Li Y; Raaby KF; Sánchez C; Gulinello M
Behav Brain Res; 2013 Nov; 256():520-8. PubMed ID: 24016840
[TBL] [Abstract][Full Text] [Related]
8. Hippocampal BMP signaling as a common pathway for antidepressant action.
Tunc-Ozcan E; Brooker SM; Bonds JA; Tsai YH; Rawat R; McGuire TL; Peng CY; Kessler JA
Cell Mol Life Sci; 2021 Dec; 79(1):31. PubMed ID: 34936033
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of vortioxetine and duloxetine on resting-state functional connectivity in the awake rat.
Pérez PD; Ma Z; Hamilton C; Sánchez C; Mørk A; Pehrson AL; Bundgaard C; Zhang N
Neuropharmacology; 2018 Jan; 128():379-387. PubMed ID: 29104073
[TBL] [Abstract][Full Text] [Related]
10. Drugs with antidepressant properties affect tryptophan metabolites differently in rodent models with depression-like behavior.
Eskelund A; Li Y; Budac DP; Müller HK; Gulinello M; Sanchez C; Wegener G
J Neurochem; 2017 Jul; 142(1):118-131. PubMed ID: 28407315
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine and 8-OH-DPAT, but not fluoxetine, reduce depression-like behaviour in an animal model of chronic neuropathic pain.
Hu B; Doods H; Treede RD; Ceci A
Neurosci Lett; 2016 Apr; 619():162-7. PubMed ID: 26987721
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice.
Guilloux JP; Mendez-David I; Pehrson A; Guiard BP; Repérant C; Orvoën S; Gardier AM; Hen R; Ebert B; Miller S; Sanchez C; David DJ
Neuropharmacology; 2013 Oct; 73():147-59. PubMed ID: 23721744
[TBL] [Abstract][Full Text] [Related]
13. The antidepressant drugs vortioxetine and duloxetine differentially and sex-dependently affect animal well-being, cognitive performance, cardiac redox status and histology in a model of osteoarthritis.
Nastić K; Pecikoza U; Labudović-Borović M; Kotur-Stevuljević J; Micov A; Jovanović A; Tomić M; Stepanović-Petrović R
Biomed Pharmacother; 2023 Oct; 166():115360. PubMed ID: 37657261
[TBL] [Abstract][Full Text] [Related]
14. Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by Aβ
Torrisi SA; Geraci F; Tropea MR; Grasso M; Caruso G; Fidilio A; Musso N; Sanfilippo G; Tascedda F; Palmeri A; Salomone S; Drago F; Puzzo D; Leggio GM; Caraci F
Front Pharmacol; 2019; 10():693. PubMed ID: 31293421
[TBL] [Abstract][Full Text] [Related]
15. Modulation of muscarinic system with serotonin-norepinephrine reuptake inhibitor antidepressant attenuates depression in mice.
Singh P; Singh TG
Indian J Pharmacol; 2015; 47(4):388-93. PubMed ID: 26288470
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: A systematic review and network meta-analysis.
Wagner G; Schultes MT; Titscher V; Teufer B; Klerings I; Gartlehner G
J Affect Disord; 2018 Mar; 228():1-12. PubMed ID: 29197738
[TBL] [Abstract][Full Text] [Related]
17. Serotonin Transporter-Independent Actions of the Antidepressant Vortioxetine As Revealed Using the SERT Met172 Mouse.
Nackenoff AG; Simmler LD; Baganz NL; Pehrson AL; Sánchez C; Blakely RD
ACS Chem Neurosci; 2017 May; 8(5):1092-1100. PubMed ID: 28272863
[TBL] [Abstract][Full Text] [Related]
18. The effects of vortioxetine on cognitive performance in working patients with major depressive disorder: A short-term, randomized, double-blind, exploratory study.
Baune BT; Sluth LB; Olsen CK
J Affect Disord; 2018 Mar; 229():421-428. PubMed ID: 29331703
[TBL] [Abstract][Full Text] [Related]
19. A single dose of vortioxetine, but not ketamine or fluoxetine, increases plasticity-related gene expression in the rat frontal cortex.
du Jardin KG; Müller HK; Sanchez C; Wegener G; Elfving B
Eur J Pharmacol; 2016 Sep; 786():29-35. PubMed ID: 27235984
[TBL] [Abstract][Full Text] [Related]
20. Vortioxetine: A Review in Cognitive Dysfunction in Depression.
Frampton JE
Drugs; 2016 Nov; 76(17):1675-1682. PubMed ID: 27807822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
